Trientine dihydrochloride is mainly used to treat Wilson’s disease, a rare genetic disorder causing copper accumulation in the body. It functions as a chelating agent, binding excess copper and promoting its excretion through urine. It is used especially in patients who are intolerant to penicillamine, another copper-chelating drug. By reducing copper levels, it helps prevent liver damage, neurological issues, and other complications of Wilson’s disease. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Syprine and Triethylenetetramine dihydrochloride. Its PubChem CID is 71433.
Trientine hydrochloride
| CAS No | 38260-01-4 |
|---|---|
| Molecular Formula | C6H20Cl2N4 |
| Molecular Weight | 219.15 g/mol |
| Synonyms | N’-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trientine dihydrochloride is mainly used to treat Wilson’s disease, a rare genetic disorder causing copper accumulation in the body. It functions as a chelating agent, binding excess copper and promoting its excretion through urine.
The listed CAS number is 38260-01-4.
The listed molecular formula is C6H20Cl2N4.
The listed molecular weight is 219.15 g/mol.
N’-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride.
The source lists Syprine and Triethylenetetramine dihydrochloride.